Iterum Therapeutics launches ORLYNVAHâ„¢, the first and only oral penem antibiotic in the U.S. Aug 20, 2025
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAHâ„¢ Launch and Commercial Growth Jun 30, 2025